Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Phase III
Case Study Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.